Search results
Beacon Therapeutics raises $170M in series B to advance gene therapies for eye disease
BioPharma-Reporter· 16 hours agoBeacon Therapeutics has closed a $170 million series B round led by Forbion, and joined by Syncona,...
Beacon Therapeutics has closed a $170 million series B round led by Forbion, and joined by Syncona,...